164 related articles for article (PubMed ID: 16879811)
1. A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation.
D'Antona AM; Ahn KH; Wang L; Mierke DF; Lucas-Lenard J; Kendall DA
Brain Res; 2006 Sep; 1108(1):1-11. PubMed ID: 16879811
[TBL] [Abstract][Full Text] [Related]
2. Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization.
D'Antona AM; Ahn KH; Kendall DA
Biochemistry; 2006 May; 45(17):5606-17. PubMed ID: 16634642
[TBL] [Abstract][Full Text] [Related]
3. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.
Ahn KH; Mahmoud MM; Kendall DA
J Biol Chem; 2012 Apr; 287(15):12070-82. PubMed ID: 22343625
[TBL] [Abstract][Full Text] [Related]
4. F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist.
Shen CP; Xiao JC; Armstrong H; Hagmann W; Fong TM
Eur J Pharmacol; 2006 Feb; 531(1-3):41-6. PubMed ID: 16438957
[TBL] [Abstract][Full Text] [Related]
5. Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.
Fay JF; Farrens DL
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8469-74. PubMed ID: 26100912
[TBL] [Abstract][Full Text] [Related]
6. An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region.
McAllister SD; Rizvi G; Anavi-Goffer S; Hurst DP; Barnett-Norris J; Lynch DL; Reggio PH; Abood ME
J Med Chem; 2003 Nov; 46(24):5139-52. PubMed ID: 14613317
[TBL] [Abstract][Full Text] [Related]
7. Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation.
McAllister SD; Hurst DP; Barnett-Norris J; Lynch D; Reggio PH; Abood ME
J Biol Chem; 2004 Nov; 279(46):48024-37. PubMed ID: 15326174
[TBL] [Abstract][Full Text] [Related]
8. Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding.
Ahn KH; Scott CE; Abrol R; Goddard WA; Kendall DA
Proteins; 2013 Aug; 81(8):1304-17. PubMed ID: 23408552
[TBL] [Abstract][Full Text] [Related]
9. Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange.
Kearn CS; Greenberg MJ; DiCamelli R; Kurzawa K; Hillard CJ
J Neurochem; 1999 Jun; 72(6):2379-87. PubMed ID: 10349847
[TBL] [Abstract][Full Text] [Related]
10. Dual role of the second extracellular loop of the cannabinoid receptor 1: ligand binding and receptor localization.
Ahn KH; Bertalovitz AC; Mierke DF; Kendall DA
Mol Pharmacol; 2009 Oct; 76(4):833-42. PubMed ID: 19643997
[TBL] [Abstract][Full Text] [Related]
11. The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice.
Breivogel CS; Vaghela MS
J Recept Signal Transduct Res; 2015 Feb; 35(1):98-106. PubMed ID: 25779032
[TBL] [Abstract][Full Text] [Related]
12. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs.
Abadji V; Lucas-Lenard JM; Chin C; Kendall DA
J Neurochem; 1999 May; 72(5):2032-8. PubMed ID: 10217281
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into CB1 cannabinoid receptor signaling: a key interaction identified between the extracellular-3 loop and transmembrane helix 2.
Marcu J; Shore DM; Kapur A; Trznadel M; Makriyannis A; Reggio PH; Abood ME
J Pharmacol Exp Ther; 2013 May; 345(2):189-97. PubMed ID: 23426954
[TBL] [Abstract][Full Text] [Related]
15. Characterization of active and inactive states of CB1 receptor and the differential binding state modulation by cannabinoid agonists, antagonists and inverse agonists.
Gullapalli S; Amrutkar D; Gupta S; Kandadi MR; Kumar H; Gandhi M; Karande V; Narayanan S
Neuropharmacology; 2010 Jun; 58(8):1215-9. PubMed ID: 20214912
[TBL] [Abstract][Full Text] [Related]
16. C-terminal truncated cannabinoid receptor 1 coexpressed with G protein trimer in Sf9 cells exists in a precoupled state and shows constitutive activity.
Chillakuri CR; Reinhart C; Michel H
FEBS J; 2007 Dec; 274(23):6106-15. PubMed ID: 17986258
[TBL] [Abstract][Full Text] [Related]
17. Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors.
MacLennan SJ; Reynen PH; Kwan J; Bonhaus DW
Br J Pharmacol; 1998 Jun; 124(4):619-22. PubMed ID: 9690851
[TBL] [Abstract][Full Text] [Related]
18. An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors.
Savinainen JR; Saario SM; Niemi R; Järvinen T; Laitinen JT
Br J Pharmacol; 2003 Dec; 140(8):1451-9. PubMed ID: 14623770
[TBL] [Abstract][Full Text] [Related]
19. The orphan receptor GPR55 is a novel cannabinoid receptor.
Ryberg E; Larsson N; Sjögren S; Hjorth S; Hermansson NO; Leonova J; Elebring T; Nilsson K; Drmota T; Greasley PJ
Br J Pharmacol; 2007 Dec; 152(7):1092-101. PubMed ID: 17876302
[TBL] [Abstract][Full Text] [Related]
20. Computational analysis of the CB1 carboxyl-terminus in the receptor-G protein complex.
Shim JY; Khurana L; Kendall DA
Proteins; 2016 Apr; 84(4):532-43. PubMed ID: 26994549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
